You just read:

Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehensive Business Plan to Fix a Failing Knight

News provided by

Medison Biotech Ltd.

Apr 08, 2019, 08:00 ET